Alcoholic extract of bacopa monniera linn. protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: A pilot study

Cellular and Molecular Neurobiology

Volumn 32, Issue 7, 2012, Pages 1099-1112

  Shobana, Chandrasekar ^a   Kumar, Radhakrishnan Ramesh ^a   Sumathi, Thangarajan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

6 Hydroxydopamine; Bacopa monniera; Behavioral parameters; Neuroprotection; Oxidative stress

Indexed keywords

ALCOHOL; BACOPA MONNIERI EXTRACT; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; OXIDOPAMINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; FORCED SWIMMING TEST; HAND GRIP; LIPID PEROXIDATION; LOCOMOTION; MALE; MAZE TEST; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; ROTAROD TEST; SUBSTANTIA NIGRA; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; BACOPA; ETHANOL; MALE; MAZE LEARNING; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOPAMINE; PILOT PROJECTS; PLANT EXTRACTS; RATS; SUBSTANTIA NIGRA;

BACOPA MONNIERI; RATTUS;

EID: 84867578575     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-012-9833-3     Document Type: Article

References (81)

1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
2. Agrawal AK, Islam F (2006) Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav 83:150-160
3. Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, Hoda MN et al (2005a) Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 24(3):137-147
4. Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB et al (2005b) Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine- induced Parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 93(1):94-104
5. Ahmad M, Yousuf S, Khan MB, Saleem S, Ishrat T, Hoda MN, Islam F (2006) Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease. Hum Exp Toxicol 25(7):361-368
6. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B (1997) Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 324:25-28
7. Bandmann O, Marsden DC, Wood NW (1998) Genetic aspects of Parkinson's disease. Mov Disord (Rev) 13:203-211
8. Bhattacharya SK, Kumar A, Ghosal S (1999) Effect of Bacopa monniera on animal models of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. Res Commun Pharmacol Toxicol 4:1-12
9. Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S (2000) Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res 14:174-179
10. Bloem BR, Irwin I, Buruma OJS, Haan J, Roos RAC, Tetrud JW et al (1990) The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J Neurol Sci 97:273-293
11. Borsini F,Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147-160
12. Breese CR, Breese GR (1998) The use of neurotoxin to lesion catecholamine neurons to model clinical disorder. In: Kostrzewa RM (ed) Highly selective neurotoxin: basic and clinical applications. Humana Press, Clifton, pp 19-73
13. Calne DB, Langston JW (1983) Aetiology of Parkinson's disease. Lancet II:1457-1459
14. Carlberg I, Mannervik B (1985) Glutathione reductase. Methods Enzymol 113:484-490
15. Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK (2006) Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiol Dis 22:421-434
16. Choi HS, Park MS, Kim SH, Hwan BY, Lee CK, Lee MK (2010) Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Molecules 15:2814-2824
17. Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC (2002) Antistress effects of bacosides of Bacopa monniera: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res 16:639-664
18. Ciobica A, Hritcu L, Artenie V, Stoica B, Bild V (2009) Effects of 6-OHDA infusion into the hypothalamic paraventricular nucleus in mediating stress induced behavioral responses and oxidative damage in rats. Acta Endocrinol (Buc) 5(4):425-436
19. Cohen G (1984) Oxyradical toxicity in catecholamine neurons. Neurotoxicology 5:77-82
20. Dean RT, Roberts CR, Jessup W (1985) Fragmentation of extracellular and intracellular polypeptides by free radicals. In: Khirallah E, Bond J, Bird JWC (eds) Intracellular protein catabolism. Liss AR, New York, pp 341-350
21. Ernst E (2006) Herbal remedies for anxiety - a systematic review of controlled clinical trials. Phytomedicine 13:205-208
22. Fearnley JM, Lees A (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114:2283-2301
23. Foyet HS, Hritcu L, Ciobica A, Stefan M, Kamtchouing P, Cojocaru D (2011) Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in 6-hydroxy dopamine lesion rodent model of Parkinson's disease. J Ethnopharmacol 133(2):773-779
24. Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47:412-426
25. Fridovich I (1975) Superoxide dismutases: an adaptation to a paramagnetic gas. J Biol Chem 264:19328-19333
26. Gurzu C, Artenie V, Hritcu L, Ciobica A (2008) Prenatal testosterone improves the spatial learning and memory by protein synthesis in different lobes of the brain in the male and female rat. Cent Eur J Biol 3(1):39-47
27. Habig WH, Pabst MJ, Jokoby WB (1974) Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139
28. Huang J, Philbert MA (1996) Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Res 711:184-192
29. Imam SZ, Ali SF (2000) Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res 855:186-191
30. Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47(6 Suppl. 3):161-170
31. Jin F, Wu Q, Lu YF, Gong QH, Shi JS (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600:78-82
32. Khuwajaa G, Khana MM, Ishrata T et al (2011) Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies. Brain Res 1368:254-263
33. Kishore K, Singh M (2005) Effect of bacosides, alcoholic extract of Bacopa monniera Linn. (brahmi), on experimental amnesia in mice. Indian J Exp Biol 43:640-645
34. Kumar R, Agarwal AK, Seth PK (1995) Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 64:1703-1707
35. Lissiana MVA, Helio VN, Danielle SM, Aline AO, Rivelilson MF, Silvania MV, Geanne MA, Francisca CF, Glauce SBV (2006) Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. Pharmacol Biochem Behav 84:415-419
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
37. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-474
38. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller D (1984) Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: possible implication in analgesic neuropathy. Cancer Res 4:5086-5091
39. Moran PM, Higgins LS, Cordell B, Moser PC (1995) Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci USA 92(12):5341-5345
40. Moron M, Depierre JW, Mannervik BT (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78
41. Myllyla VV, Sotaniemi KA, Vuorinen JA, Heinone EH (1992) Selegiline as initial treatment in de novo Parkinsonian patients. Neurology 42:339-343
42. Nathan PJ, Clarke J, Lloyd J, Huchison CW, Downey L, Stough C (2001) The acute effects of an extract of Bacopa monniera on cognitive function in healthy normal subjects. Hum Psychopharmacol 16:345-351
43. Nilsson FM, Kessing LV, Bolwig TG (2001) Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104:380-386
44. Parkinson Study Group (1989) Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 321:1364-3171
45. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York.
46. Perese DA, Ulman J, Viola J, Ewing SE, Bankiewicz KS (1989) A 6-hydroxydopamine induced selective Parkinsonian rat model. Brain Res 494:285-293
47. Perumal AS, Gopal VB, Tordzro WK, Cooper TB, Cadet JL (1992) Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res Bull 29:699-701
48. Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177:245-255
49. Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732
50. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391
51. Roghani M, Behzadi G (2001) Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. Brain Res 892:211-217
52. Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J (2002) Chronic effects of Brahmi (Bacopa monniera) on human memory. Neuropsychopharmacology 27:279-281
53. Russo A, Borrelli F (2005) Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 12:305-317
54. Russo A, Izzo AA, Borrelli F, Renis M, Vanella A (2003) Free radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damage. Phytother Res 17:870-875
55. Sachs C, Jonsson G (1975) Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24:1-8
56. Sairam K, Rao CV, Goel RK (2001) Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine 8:423-430
57. Saraf MK, Prabhakar S, Pandhi P, Anand A (2008) Bacopa monniera ameliorates amnesic effects of diazepam qualifying behavioral- molecular partitioning. Neuroscience 155:476-484
58. Schurman AG, van den Akker M, Ensinck KT, Metsemakers JF, Knottnerus JA, Leentjens AF, Buntinx F (2002) Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 58:1501-1504
59. Schwarting RK, Bonatz AE, Carey RJ, Huston JP (1991) Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections. Brain Res 554:46-55
60. Shanker G, Singh HK (2000) Anxiolytic profile of standardized Brahmi extract. Indian J Pharmacol 32:152
61. Sharma R, Chaturvedi C, Tewari PV (1987) Efficacy of Bacopa monniera in revitalizing intellectual functions in children. J Res Educ Indian Med 1:12
62. Singh HK, Dhawan BN (1982) Effect of Bacopa monniera Linn. (brahmi) extract on avoidance responses in rat. J Ethnopharmacol 5:205-214
63. Singh HK, Dhawan BN (1997) Neuropsychopharmacological effects of the ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian J Pharmacol 29:359-365
64. Singh HK, Rastogi RP, Srimal RC, Dhawan BN (1988) Effects of bacosides A and B on avoidance response in rats. Phytother Res 2:70-75
65. Slater TF (1984) Free radical mechanisms in tissue injury. Biochem J 222:1-12
66. Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP (2001) Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13:187-196
67. Stolberg A (2005) Ranking of memories and behavioral strategies in the radial maze. Acta Neurobiol Exp (Wars) 65(1):39-49
68. Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, Nathan PJ (2001) The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berlin) 156:481-484
69. Sumathi T, Niranjali Devaraj S (2009) Effect of Bacopa monniera on liver and kidney toxicity in chronic use of opioids. Phytomedicine 16:897-903
70. Sumathi T, Nongbri A (2008) Hepatoprotective effect of Bacoside-A, a major constituent of Bacopa monniera Linn. Phytomedicine 15:901-905
71. Sun Y (1990) Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med 8:583-599
72. Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP (1996) Bacopa monniera Linn. as an antioxidant: mechanism of action. Indian J Exp Biol 34:523-526
73. Tuncel N, Korkmaz OT, Tekin N, Sener E, Akyuz F, Inal M (2012) Antioxidant and antiapoptotic activity of vasoactive intestinal peptide against 6-hydroxy dopamine toxicity in the rat corpus striatum. J Mol Neurosci 46(1):51-57
74. Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central dopamine neurons. Eur J Pharmacol 5:107-110
75. Utley HC, Bernheim F, Hochslein P (1967) Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 260:521-531
76. Vohora D, Pal SN, Pillai KK (2000) Protection from phenytoin induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant. J Ethnopharmacol 71:383-390
77. Vollala VR, Upadhya S, Nayak S (2010) Effect of Bacopa monniera Linn. (Brahmi) extract on learning and memory in rats: a behavioral study. J Vet Behav 5:69-74
78. Whishaw IQ, Li K, Whishaw PA, Gorny B, Metz GA (2008) Use of rotorod as a method for the qualitative analysis of walking in rat. J Vis Exp 22. doi:10.3791/1030
79. Zafar KS, Sayeed I, Siddiqui A, Ahmad M, Salim S, Slam F (2003a) Dose-dependent protective effect of selenium in partial lesion model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Neurochem 84:438-446
80. Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Saleem S, Islam F (2003b) Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Chem Neuroanat 26:143-151
81. Ziv I, Melamed E, Nardi N (1998) Role of apoptosis in the pathogenesis of Parkinson's disease: a novel therapeutic opportunity. Mov Disord 13:865-870